Non-Invasive Monitoring Device Market report analysis is done by experts which gives in-depth detail information about Non-Invasive Monitoring Device industry segmentation, regional data & industry key players.
Monitoring patients, if possible round-the-clock, is one necessary part of treatment. Such steps help in maintaining the constant care of the patients. With growing technological assistance in the segment, people are now opting for various monitoring devices that are non-invasive. This provides easy operational techniques, regular check-ups, better initiation of preventive measures, and others. However, invasive and minimally-invasive monitoring devices have a substantial market presence as well. But the non-invasive ones are gaining prominence. The global non-invasive monitoring devices market can inspire growth by 6.80% CAGR over the review period of 2014 to 2023 with Market Research Future (MRFR) claiming that the move may take the global market forward and enable it to cross a valuation of USD 21,586.2 million by the end of the forecast period.
Factors like advancement in technology, better investment capacity, high investment in the healthcare sector, better innovation and spending for research & development can take the global non-invasive monitoring device market forward.
SAMPLE COPY IS AVAILABLE HERE @ https://www.marketresearchfuture.com/sample_request/1506
- In August 2018, Abbott entered into an agreement with Roxwood Medical for product distribution in the US.
- In July 2017, Koninklijke Philips NV acquired PathXL to expand its business leaders in the medical device industry.
- In August 2017, Integrity Applications received USFDA approval for the insertable cardiac monitor, the world’s first smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias.
A detailed study of the global non-invasive monitoring device market is founded on type, application, modality, and end user. The segmentation simplifies the understanding of factors that can impact the global market.
- By type, the market for non-invasive monitoring device covers anesthesia monitoring devices, cardiac monitoring devices (electrocardiography & cardiac output monitors), blood pressure monitoring devices, brain monitoring devices, and blood glucose monitoring devices.
- By modality, the market for non-invasive monitoring device includes table-top devices and wearable devices.
- By application, the non-invasive monitoring device market includes neurology, cardiology, and oncology.
- By end-user, the market segmentation includes diagnostic centers, hospital & clinics, and research & academic institutes. The hospitals & clinics segment had a valuation of USD 5457.4 million in 2016.
The Americas and Europe are regions that have the potential to take the global non-invasive monitoring device market ahead as their technological prowess is expected to make sure that the market moves ahead at a substantial pace. Investment in the market are also flowing in substantially to make sure that the growth flows forward uninterrupted. The market is further getting bolstered by high per capita income.
The APAC market is having a strong growth due to continuous investment made by emerging economies like China, India, Japan, and others. These countries are assisting in expanding the market as rise in per capita income of the middle class that includes a massive population is impacting the market.
The global market for non-invasive monitoring devices is witnessing a substantial growth due to the growing impact of involved companies who are implementing the various strategic moves. The moves are addressed to cement these companies’ market position and make holistic changes in the global market scenario. MRFR enlisted a few companies in the report to make sure that it provides a better grip over the market in the coming years to enable better assessment. These companies are Medtronic PLC (Ireland), General Electric Company (US), Abbott (US), KONINKLIJKE PHILIPS NV (Netherlands), Vaso Corporation (US), Omron Corporation (Japan), CAS Medical Systems, Inc. (US), Integrity Applications (Israel), Tensys Medical Inc (US), NIMedical (Israel), A&D Medical Inc. (Japan), CNSystems Medizintechnik AG (Austria), OrSense Ltd (Israel), and Advanced Brain Monitoring, Inc (US).
In September 2019, various researchers from the ICFO published an article in the Science Advances that people are now opting for devices that are flexible and transparent, and most importantly, these devices are wearable. These products are conformable to the skin and can continuously measure multiple vital signs to determine the state of health. Among various benefits, these devices can detect heart rate, blood pulse oxygenation, respiration rate, UV radiation exposure, and others. The nanomaterial graphene, boosted by advanced light-sensing technology can trigger better growth for the market. The material is highly flexible and is made of transparent material comprising one-atom-thick layer of carbon atoms. The light-absorbing layer is founded on quantum dots.
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
Chapter 3. Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Market Pricing Approach
3.2 Market Size Estimation
3.3 Forecast Model
ACCESS THE FULL REPORT WITH TOC @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312